Genentech

12 results

Genentech says Amgen Inc and Amgen Technology (Ireland), with its registered office in Dublin, is infringing a protection certificate it enjoys on its patent for its product, Avastin

A US biotechnology company claims an Irish rival is infringing its patent on a widely-used cancer treatment drug that sold more than $9 billion (€8 bi(...)

Tesaro brings to GSK a marketed product for ovarian cancer, Zejula, which belongs to a promising new class of medicines.  Photograph: Toby Melville/Reuters

GlaxoSmithKline has agreed to buy US cancer specialist Tesaro for $5.1 billion (€4.5 billion), marking a major biotech investment by chief executive E(...)

Valitacell chief executive Dr Terry McWade: co-founded the company with Dr Jerry Clifford.

An Irish start-up has big plans to provide specialised services for the world’s biggest pharmaceutical companies. Its client list so far includes US (...)

Dr Vishva Dixit: “Thanks to the new immunotherapies, we’re seeing patients today who should have been dead, but are still alive after seven years and counting”

The cost of groundbreaking but hugely expensive new cancer drugs could be reduced by governments agreeing to lengthen the patents on them, a leading i(...)

Almac Discovery, the Northern Ireland biopharmaceutical company, has agreed a drug development deal with Genentech which could be worth more than £225 million (€311 million).

Almac Discovery, the Northern Ireland biopharmaceutical company, has agreed a drug development deal with Californian-based Genentech which could be wo(...)

Roche, the world’s largest maker of cancer drugs, will pay $74 a share for InterMune, an unprofitable biotechnology company that’s awaiting US approval of its biggest drug.Photograph: STEFFEN SCHMIDT/EPA

Roche Holding, the world’s largest maker of cancer drugs, is strengthening its portfolio of medicines for respiratory ailments with an agreement to bu(...)

Peter Diamandis, chairman and chief executive of the X Prize Foundation: “Most CEOs today are focused on quarterly returns . . . They are unaware of [what is coming down the track] which will be massively disruptive”. Photograph: Nadine Rupp/Getty Images

Dr Peter Diamandis is a man who sees the future in the present. His mission he says is “to open the space frontier for humanity” and he believes it is(...)

Biotech fever is spreading to Europe from the United States with a successful stock market debut for a cat allergy company in Britain seen as a(...)

 Christoph Franz (left), designated chairman of the board, speaks to Franz B Humer, outgoing chairman of the board of Roche, during the general assembly of Swiss pharmaceutical company Roche Holding AG in Basel, Switzerland, yesterday. Photograph: EPA/Patrick Straub

Roche’s new chairman has signalled his intention to follow his predecessor’s tight-fisted approach toward acquisitions even now that the drugma(...)

Larry Page: The new company will focus on issues such as decreased mobility and mental agility in addition to life-threatening diseases. Photograph:  Emmanuel Dunand/AFP/Getty Images

Having mapped the earth, developed “smart glasses” and cars that drive by themselves, the next big issue that Google plans to target is old age. In a (...)

  • 1
  • 2
  • Next
  • Last »